Partnerships with patient organizations aim at a united approach to enhance patients’ quality of life and highlight their needs and experience.
The Hellenic Cancer Federation-ELLOK is the national umbrella organization of Cancer Patient Associations. It represents 40 Cancer Patient Organisations – members across Greece, advocating for all cancers, including common, rare, and pediatric cancers. ELLOK’s vision is to achieve optimal, equal, and universal access to care for all cancer patients, assuring excellent diagnosis, treatment, psycho-social support, and survivorship care, including rehabilitation and reintegration into social life. ELLOK’s mission is to advocate for cancer policy and research, as well as to foster cancer patients’ rights for equal, universal, and unhindered access to timely diagnosis, treatment, and care through joining forces with all our members and stakeholders related to cancer care.
Greek Association of Patients with CLL
The Greek Association of Patients with CLL was founded in 2017 and is a non-profit entity. The basic aims of the association are:
- The provision of every kind of assistance, support, and care, as well as the promotion by every legal means of the interests, and the effort to solve the problems of patients with CLL.
- Informing and enlightening the public about hematological diseases and available treatments, particularly concerning patients with CLL.
- The organization of seminars, conferences, lectures, discussions, and any other relevant activity that promotes science, as well as improves the medical care and support to the members of the association.
The European Hematology Association (EHA) is a membership organization serving clinicians and researchers with an active interest in hematology in Europe and beyond. EHA brings together relevant stakeholders to promote excellence in patient care through education, research, and advocacy. EHA’s Mission is “Towards a cure for all blood disorders”. We do this through connecting hematologists wordwide, advocating the interests of hematologists and hematology, supporting career development and research, and harmonizing hematology education.
Οur aim is to improve the quality of life of thousands of people and contribute to society by developing and marketing innovative medicines. Driven by science, we invest in years of research and clinical trials and leverage cutting-edge scientific breakthroughs, setting new standards in the prevention and treatment of major diseases such as cancer, diabetes, heart, kidney, respiratory and rare diseases. Our driving force is our people, who follow our values and work with passion and dedication. We have a talented team of people with an entrepreneurial, collaborative culture open to new ideas. We are a trusted partner and an important ally in the fight to address current and future public health challenges.